AprilBio Co.,Ltd. (KOSDAQ:397030)
55,200
+1,500 (2.79%)
At close: May 19, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 1.2 trillion as of May 20, 2026. Its market cap has increased by 281.87% in one year.
Market Cap
1.20T
Enterprise Value
1.11T
Revenue
2.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
55,200.00
Market Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 1.20T, an increase of 423.25%. That is a compound annual growth rate of 54.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 1.29T | 1.13% |
| Dec 30, 2025 | 1.27T | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
| Jul 28, 2022 | 229.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JS Link | 1.23T |
| Qurient | 1.12T |
| Inventage Lab | 723.61B |
| Curocell | 650.31B |
| IMBiologics | 605.82B |
| Kangstem Biotech | 309.91B |
| curacle co.,ltd. | 303.16B |
| TiumBio | 297.57B |